Menopause Weight Loss Breakthrough: Hormone Therapy Boosts Results
New research shows combining menopause hormone therapy with tirzepatide increases weight loss to 17% in postmenopausal women with obesity.
Gates Commits $100M to Women’s Health Research Breakthrough
Melinda French Gates announces $100M partnership with Wellcome Leap to accelerate women's health research in cardiovascular, autoimmune, and mental health.
Harvard Receives $50M for Organ Chip Technology to Transform Care
Harvard's Wyss Institute receives Wellcome Leap funding to develop first organ chip technology model for heavy menstrual bleeding, aiming to reduce treatment time.
Revolutionary Menstrual Health Technology Transforms Women’s Care
Truelli unveils groundbreaking menstrual health technology with smart pads that analyze blood for comprehensive health monitoring, revolutionizing women's healthcare.
FDA Issues Acetaminophen Pregnancy Warning Amid Autism Concerns
The FDA issued an acetaminophen pregnancy warning following Trump administration claims linking the pain reliever to autism risk, sparking medical debate.
Women’s Health Initiative Faces Major Funding Cuts by HHS
HHS cuts funding for the Women's Health Initiative, threatening the largest women's health study in U.S. history that has followed over 160,000 women since 1991.
FDA Approves First At-Home Cervical Cancer Screening Device
The FDA approval of Teal Wand marks a breakthrough in women's health, offering the first at-home cervical cancer screening alternative to traditional Pap smears.
Smart Menstrual Pad Tech Transforms Women’s Health Screening
Truelli's revolutionary smart menstrual pad technology analyzes period blood for health insights, offering instant at-home screening for women nationwide.
Removing Hormone Therapy Warnings, After Medical Experts Shocking Discovery
FDA experts urge removal of hormone therapy FDA black box warnings, citing outdated risks and benefits for menopausal women seeking treatment relief.
FDA Approves First Device for Asherman Syndrome, Addressing Infertility
FDA approves Womed Leaf, the first medical device for Asherman syndrome, which affects 20-45% of women after uterine procedures and causes infertility.